Skip to content
Home/Companies/Pharma/Axience
Axience

Axience

Pharma·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Axience?

Axience is currently owned by Motion Equity Partners through Motion Equity Partners Fund (2024 vintage), since 2024.

Hand-verified · updated 2026-04-21

Motion Equity Partners
Investor
Motion Equity Partners
Motion Equity Partners Fund · 2024 · Buyout

Key facts

HQFrance
SectorPharma
Websitewww.axience.fr

More from Motion Equity Partners Fund

Other portfolio companies in the same fund.

Polaris
Polaris
Active
HealthcareFrance· 2026
Sileane
Active
IndustrialsFrance· 2025
Siléane
Siléane
Active
IndustrialsFrance· 2025
Banook
Banook
Active
MedTechFrance· 2024
Tournaire
Tournaire
Active
IndustrialsFrance· 2023
Résilians
Active
ConstructionFrance· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Axience

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Axience?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Axience.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue